Compare VHC & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VHC | BNGO |
|---|---|---|
| Founded | 2005 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Biotechnology: Laboratory Analytical Instruments |
| Sector | Miscellaneous | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.2M | 11.6M |
| IPO Year | 2008 | 2018 |
| Metric | VHC | BNGO |
|---|---|---|
| Price | $14.05 | $1.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.33 |
| AVG Volume (30 Days) | 8.9K | ★ 257.0K |
| Earning Date | 03-24-2026 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.99 | ★ 94.50 |
| EPS | N/A | ★ N/A |
| Revenue | $162,000.00 | ★ $12,000,735.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | N/A | $48.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3140.00 | 26.26 |
| 52 Week Low | $6.60 | $1.06 |
| 52 Week High | $29.00 | $5.50 |
| Indicator | VHC | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 41.41 | 47.01 |
| Support Level | $12.88 | $1.07 |
| Resistance Level | $18.36 | $1.18 |
| Average True Range (ATR) | 1.41 | 0.07 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 16.95 | 13.51 |
VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.